The application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric study

Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSPSILVA, Fernanda Borges daFIGUEIREDO-PONTES, Lorena Lobo deMADEIRA, Maria Isabel AyrosaKOURY, Luisa Correa de AraujoLIMA, Ana Silvia Gouvea deSCHEUCHER, Priscila SantosCOELHO-SILVA, Juan LuizPAGNANO, Katia Borgia BarbosaPALLOTA, RonaldCHAUFFAILLE, Maria de LourdesOLTRAMARI, Marcos Roberto PedronBITTENCOURT, Rosane IsabelHIGASHI, MarciaBENDLIN, Rodrigo MiguelVELLOSO, Elvira Deolinda Rodrigues PereiraLOWENBERG, BobGANSER, ArnoldBERLINER, NancyVALK, PeterREGO, Eduardo MagalhaesTRAINA, Fabiola2018-03-062018-03-062017BLOOD ADVANCES, v.1, suppl.1, p.86-89, 20172473-9529https://observatorio.fm.usp.br/handle/OPI/25469engrestrictedAccessinternational expert panelrecommendationsmanagementdiagnosisThe application of an integrated clinical, cytogenetic, and molecular risk stratification for acute myeloid leukemia patients using a central laboratory in a Brazilian multicentric studyarticleCopyright AMER SOC HEMATOLOGY10.1182/bloodadvances.2017GS102419Hematology2473-9537